FindTrial
Sign In

RESEARCH STUDY ON COVID19 ANTIBODIES IN HEALTH CARE WORKERS AT TERTIARY CARE HOSPITAL

COVID19 SEROLOGY IN HEALTH CARE WORKERS AT TERTIARY CARE CENTRE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/030052
Enrollment
120
Registered
2020-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

SRM
Lead Sponsor
DrRBhuvanamha Devi Self
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All Health care workers working in SRM MCH & RC, Potheri In Covid 19 â?? ICU Wards and OP clinic In non-COVID 19 ICU Wards and OP Clinics Without daily patient contact Healthy individuals as Controls

Exclusion criteria

Exclusion criteria: Individuals with typical symptoms of COVID 19 Individuals not giving Consent for the study

Design outcomes

Primary

MeasureTime frame
To evaluate the sero-prevalence of IgG Sar-CoV2 in Health care workers who are exposed to COVID-19 patients, in SRM MCH&RC, Tertiary care Hospital.Timepoint: 4 to 8weeks—

Secondary

MeasureTime frame
Identifying these individuals at earliest allows close follow-up for screening them to assess and prevent end organ damage. To reassure our HCWs that they are not infected and to adhere, the same precautionary measures that they were following. Timepoint: 10to12weeks—

Countries

India

Contacts

Public ContactBhuvanamha Devi Ramamurthy

SRM institute of Science and Technology

drrbdevipath@gmail.com8148840658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026